Dysmyelinogenesis in animal model of GM1 gangliosidosis-Reference-Cited by-同舟云学术

Dysmyelinogenesis in animal model of GM1 gangliosidosis

Published:1992-07 Issue:4 Volume:8 Page:255-261
ISSN:0887-8994
Container-title:Pediatric Neurology
language:en
Short-container-title:Pediatric Neurology

Author:

Kaye Edward M.,Alroy Joseph,Raghavan Srinivasa S.,Schwarting Gerald A.,Adelman Lester S.,Runge Val,Gelblum Dafna,Thalhammer Johann G.,Zuniga Gonzalo

Publisher

Elsevier BV

Subject

Neurology (clinical),Developmental Neuroscience,Neurology,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Familial neurovisceral lipidosis: An analysis of eight cases of a syndrome previously reported as “Hurler-variant,” “Pseudo-Hurler disease,” and “Tay-Sachs disease with visceral involvement”;Landing;Am J Dis Child,1964

2. β-Galactosidase deficiency (GM1 gangliosidosis, galactosialidosis, and Morquio syndrome type B): Ganglioside sialidase deficiency (mucolipidosis IV);O'Brien,1989

3. GM1 gangliosidosis in Portuguese water dogs: Pathologic and biochemical findings;Saunders;Vet Pathol,1988

4. Neuronal-visceral GM1 gangliosidosis in Portuguese water dogs;Shell;J Vet Intern Med,1989

5. Neurovisceral and skeletal GM1-gangliosidosis in dogs with beta-galactosidase deficiency;Alroy;Science,1985

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GM1 gangliosidosis type II: Results of a 10-year prospective study;Genetics in Medicine;2024-07

2. GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study;2024-01-04

3. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

4. Ganglioside GM1 and the Central Nervous System;International Journal of Molecular Sciences;2023-05-31

5. Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients;Molecular Genetics and Metabolism Reports;2022-03